| scholarly article | Q13442814 |
| P356 | DOI | 10.1179/1973947815Y.0000000069 |
| P698 | PubMed publication ID | 26358183 |
| P2093 | author name string | Branka Bedenić | |
| Karmen Godič Torkar | |||
| Vanda Plečko | |||
| P2860 | cites work | Control of cell morphogenesis in bacteria: two distinct ways to make a rod-shaped cell | Q33187415 |
| Bacillus cereus, a volatile human pathogen | Q33825596 | ||
| Antimicrobial susceptibility testing of Bacillus anthracis: comparison of results obtained by using the National Committee for Clinical Laboratory Standards broth microdilution reference and Etest agar gradient diffusion methods | Q34197221 | ||
| Effective antimicrobial regimens for use in humans for therapy of Bacillus anthracis infections and postexposure prophylaxis | Q34228256 | ||
| Imaging peptidoglycan biosynthesis in Bacillus subtilis with fluorescent antibiotics | Q34984274 | ||
| Differential effects of linezolid and ciprofloxacin on toxin production by Bacillus anthracis in an in vitro pharmacodynamic system | Q35666418 | ||
| Drug interactions with Bacillus anthracis topoisomerase IV: biochemical basis for quinolone action and resistance | Q35682250 | ||
| The Bacillus cereus group: novel aspects of population structure and genome dynamics | Q36565147 | ||
| MICs of selected antibiotics for Bacillus anthracis, Bacillus cereus, Bacillus thuringiensis, and Bacillus mycoides from a range of clinical and environmental sources as determined by the Etest | Q37157142 | ||
| In vitro activities of daptomycin, ciprofloxacin, and other antimicrobial agents against the cells and spores of clinical isolates of Bacillus species | Q38479126 | ||
| In vitro bactericidal activities of linezolid in combination with vancomycin, gentamicin, ciprofloxacin, fusidic acid, and rifampin against Staphylococcus aureus | Q39730651 | ||
| Use of the microbial growth curve in postantibiotic effect studies of Legionella pneumophila | Q39731821 | ||
| Postantibiotic effect of beta-lactam antibiotics on Escherichia coli evaluated by bioluminescence assay of bacterial ATP. | Q39815200 | ||
| Bacillus cereus infections in Traumatology-Orthopaedics Department: retrospective investigation and improvement of healthcare practices | Q42642856 | ||
| Aerobic spore-forming bacteria for assessing quality of drinking water produced from surface water | Q43328842 | ||
| Post-antibiotic growth suppression of linezolid against Gram-positive bacteria | Q43627866 | ||
| Evidence for a true post-beta-lactamase-inhibitor effect of clavulanic acid against Klebsiella pneumoniae and Haemophilus influenzae | Q43885666 | ||
| Bacillus cereus heteroresistance to carbapenems in a cancer patient | Q43996158 | ||
| A patient with acute myeloid leukemia who developed fatal pneumonia caused by carbapenem-resistant Bacillus cereus | Q44238511 | ||
| Fatal Bacillus cereus sepsis following resolving neutropenic enterocolitis during the treatment of acute leukemia | Q44327931 | ||
| Bacillus spp. among hospitalized patients with haematological malignancies: clinical features, epidemics and outcomes | Q44553888 | ||
| Post-antibiotic and post-beta-lactamase inhibitor effects of ceftazidime plus sulbactam on extended-spectrum beta-lactamase-producing Gram-negative bacteria | Q44777346 | ||
| In vitro post-antibiotic effect of fluoroquinolones, macrolides, beta-lactams, tetracyclines, vancomycin, clindamycin, linezolid, chloramphenicol, quinupristin/dalfopristin and rifampicin on Bacillus anthracis | Q44785402 | ||
| Influence of the cell wall on ciprofloxacin susceptibility in selected wild-type Gram-negative and Gram-positive bacteria | Q44934012 | ||
| Bacillus cereus from blood cultures: virulence genes, antimicrobial susceptibility and risk factors for blood stream infection | Q44989107 | ||
| Postantibiotic effect of antimicrobial combinations on multidrug-resistant Pseudomonas aeruginosa. | Q45255738 | ||
| Geographical distribution of genotypic and phenotypic markers among Bacillus anthracis isolates and related species by historical movement and horizontal transfer | Q46043313 | ||
| Ciprofloxacin pharmacokinetics in critically ill patients: a prospective cohort study | Q46412788 | ||
| Serum levels of ciprofloxacin after single oral doses in patients with septicemia. | Q54721961 | ||
| Comparison of teicoplanin and vancomycinin vitroactivity on clinical isolates ofStaphylococcus aureus | Q58864093 | ||
| P433 | issue | 3 | |
| P921 | main subject | Bacillus cereus | Q131307 |
| vancomycin | Q424027 | ||
| P304 | page(s) | 151-158 | |
| P577 | publication date | 2015-09-11 | |
| P1433 | published in | Journal of Chemotherapy | Q15754073 |
| P1476 | title | Antimicrobial susceptibility and the in vitro postantibiotic effects of vancomycin and ciprofloxacin against Bacillus cereus isolates | |
| P478 | volume | 28 |
| Q52597653 | Prevalence, Virulence Genes, Antimicrobial Susceptibility, and Genetic Diversity of Bacillus cereus Isolated From Pasteurized Milk in China. | cites work | P2860 |
Search more.